Previous Article | Next Article 
J Virol, June 1998, p. 4811-4818, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Rescue and Autonomous Replication of
Adeno-Associated Virus Type 2 Genomes Containing Rep-Binding
Site Mutations in the Viral p5 Promoter
Xu-Shan
Wang1,2,3 and
Arun
Srivastava1,2,3,4,*
Department of Microbiology and
Immunology,1
Walther Oncology
Center,2 and
Division of
Hematology/Oncology, Department of
Medicine,4 Indiana University School of
Medicine, and
Walther Cancer
Institute,3 Indianapolis, Indiana 46202
Received 3 December 1997/Accepted 11 February 1998
 |
ABSTRACT |
The Rep proteins encoded by the adeno-associated virus type 2 (AAV)
play a crucial role in the rescue, replication, and integration of the
viral genome. In the absence of a helper virus, little expression of
the AAV Rep proteins occurs, and the AAV genome fails to undergo DNA
replication. Since previous studies have established that expression of
the Rep78 and Rep68 proteins from the viral p5 promoter is controlled
by the Rep-binding site (RBS) and the YY1 factor-binding site (YBS), we
constructed a number of recombinant AAV plasmids containing mutations
and/or deletions of the RBS and the YBS in the p5 promoter. These
plasmids were transfected in HeLa or 293 cells and analyzed for the
potential to undergo AAV DNA rescue and replication. Our studies
revealed that (i) a low-level rescue and autonomous replication of the wild-type AAV genome occurred in 293 but not in HeLa cells; (ii) mutations in the RBS resulted in augmented expression from the p5
promoter, leading to more efficient rescue and/or replication of the
AAV genome in 293 but not in HeLa cells; (iii) little rescue and/or
replication occurred from plasmids containing mutations in the YBS
alone in the absence of coinfection with adenovirus; (iv) expression of
the adenovirus E1A gene products was insufficient to mediate rescue
and/or replication of the AAV genome in HeLa cells; (v) autonomously
replicated AAV genomes in 293 cells were successfully encapsidated in
mature progeny virions that were biologically active in secondary
infection of HeLa cells in the presence of adenovirus; and (vi) stable
transfection of recombinant AAV plasmids containing a gene for
resistance to neomycin significantly affected stable integration only
in 293 cells, presumably because rescue and autonomous replication of
the AAV genome from these plasmids occurred in 293 cells but not in
HeLa or KB cells. These data suggest that in the absence of adenovirus,
the AAV Rep protein-RBS interaction plays a dominant role in
down-regulating viral gene expression from the p5 promoter and that
perturbation in this interaction is sufficient to confer autonomous
replication competence to AAV in 293 cells.
 |
INTRODUCTION |
The adeno-associated virus type 2 (AAV), a nonpathogenic human parvovirus, contains a single-stranded DNA
genome of 4,680 nucleotides (55). Optimal replication of the
wild-type (wt) AAV genome requires coinfection with a helper virus,
such as adenovirus or herpesvirus (2-5). In the absence of
a helper virus, the wt AAV genome integrates into the host chromosomal
DNA in a site-specific manner to establish a latent infection (7,
17-20, 48). When a latently infected cell is subsequently
infected with a helper virus, the integrated wt AAV genome undergoes
rescue and proceeds through a normal productive infection (31,
32). The AAV genome can also be rescued from recombinant plasmids
containing the wt viral genome by transfecting the plasmid DNA into
adenovirus-infected human cells (44, 47). Thus, recombinant
plasmids have proven to be a useful model system with which to study
the molecular events involved in rescue and replication of the latent
proviral AAV genome (10, 44-46, 56, 59-61). Two sequences
in the wt AAV genome are essential for viral DNA replication. The first
is the viral origin of DNA replication, which consists of a
145-nucleotide inverted terminal repeat (ITR) sequence, the terminal
125 nucleotides of which form a hairpin palindrome that is used as a
primer for initiation of viral DNA replication (9, 26, 54).
The second is the viral rep gene, which codes for four viral
nonstructural proteins (Rep) that are synthesized from a single open
reading frame by the use of alternate promoters and splicing
(54). Rep78 and Rep68 are expressed from a promoter at map
unit 5 (p5), and Rep52 and Rep40 are derived from expression from a
promoter at map unit 19 (p19) in the viral genome (3, 4, 30,
54). The Rep proteins have multiple functions and are involved in
rescue, replication, encapsidation, and integration of the AAV genome as well as in regulation of the viral gene expression (12, 13, 24-30, 35-38, 49, 52, 53, 56, 63, 64). In the absence of
adenovirus, the Rep proteins repress the production of the p5 and p19
transcripts, but in the presence of adenovirus, the Rep proteins
simultaneously activate and repress the AAV p5 promoter and activate
expression from the p19 promoter in the AAV genome (37, 38).
Previous studies have shown that Rep78 and Rep68 specifically bind to
the cruciform structures of the AAV ITRs (1, 14). The Rep
proteins also possess a site-specific and strand-specific endonuclease
activity which specifically cleaves at the terminal resolution site
(trs) within the ITR sequences (15, 16). Both the
secondary structure element of the ITR and a specific sequence at
trs are required for the recognition and efficient cleavage
by the Rep proteins (52, 53), although a low-level cleavage
can occur in the absence of the secondary structure (27).
However, recent in vitro studies have documented that the purified
Rep68 protein binds not only to the ITR but also to linear DNA
sequences, such as the A sequence, and p5 and p19 promoter sequences
(24, 27, 37, 62). The Rep-binding site (RBS) in the p5
promoter between the TATA box and the transcription start site is
responsible for the repression of expression of Rep68 (24,
37). In addition to this RBS, the binding site for yet another
transcription factor, YY1 (58) (the YY1 factor-binding site
[YBS]), in the p5 promoter is also responsible for regulation of
expression of Rep proteins (6, 50, 51). Although the RBS in
the p5 promoter is believed to be involved in rep gene expression (24, 35) and AAV DNA integration (8),
it is unclear whether Rep-mediated binding to these sequences is
required for viral DNA replication. Similarly, the binding of YY1 to
the p5 promoter and its consequences for AAV DNA replication in the absence of a helper virus have not been rigorously examined.
In this report, we document that the wt AAV genome undergoes rescue and
autonomous replication in 293 but not in HeLa cells and that autonomous
replication of the AAV genome correlates well with expression from the
viral promoters in 293 cells. Interestingly, however, expression of the
adenovirus E1A proteins is insufficient to mediate rescue and
replication of the AAV genome in HeLa cells. The autonomously
replicated AAV genomes in 293 cells are successfully encapsidated in
mature progeny virions that are biologically active. These studies
yield insights into the complex interaction of Rep proteins with the
viral genome leading to down-regulation of gene expression from the p5
promoter and indicate that perturbation in this interaction is
sufficient to confer autonomous replication competence to AAV in 293 cells.
 |
MATERIALS AND METHODS |
Cells, viruses, and plasmids.
Human cervical carcinoma cell
line HeLa and human nasopharyngeal carcinoma cell line KB were provided
by Asok C. Antony (Indiana University School of Medicine,
Indianapolis). Human embryonic kidney cell line 293 was obtained from
the American Type Culture Collection (Rockville, Md.). Cells were
maintained as monolayer cultures in Iscove's modified Dulbecco's
medium supplemented with 10% fetal bovine serum, penicillin, and
streptomycin as previously described (33, 34). AAV and the
human adenovirus type 2 (Ad2) virus stocks were obtained from Kenneth
I. Berns, Cornell University Medical College, New York, N.Y., and
Kenneth H. Fife, Indiana University School of Medicine, respectively,
and propagated as previously described (21). The recombinant
AAV plasmid pSub201 (45) was supplied by Richard
J. Samulski, University of North Carolina, Chapel Hill.
Construction of recombinant AAV plasmids.
Standard cloning
techniques were used for constructing all recombinant plasmids
(43). First, a plasmid designated pXS-26B was constructed by
replacing the right XbaI site in plasmid pSub201 with a synthetic oligonucleotide linker sequence
(5'-CTAGGGAATTCC-3') containing an EcoRI site. To
construct plasmids pXS-70A, pXS-70B, and pXS-70C, plasmid
pSub201 was digested with Eco31I and
KpnI. The left half of the AAV genome fragment was isolated
and ligated with synthetic oligonucleotide linker sequences
(5'-CCGAGATCTCGATCAGGGTCTCC-3', 5'-CCGAGTGAGCACGCAGGGTTTAA-3',
and 5'-CCGAGATCTCGTCAGGGTTTAA-3', respectively) and
then inserted into plasmid pXS-24, described previously
(60), which was digested with AvaI and
KpnI. The resulting plasmids, designated pXS-69A, pXS-69B,
and pXS-69C, respectively, were digested with XbaI and
HindIII, and these fragments were used to replace the
XbaI-HindIII fragment in plasmid pXS-26B. Plasmid pXS-48B was constructed by replacing the
XbaI-HindIII fragment of pXS-26B, using the
XbaI-HindIII fragment from pXS-47, also
described previously (62). The wt AAV coding sequences flanked by the Ad5 ITRs were cloned between the BalI sites
in plasmid pSub201 to generate plasmid pXS-37. A DNA
fragment containing the herpesvirus thymidine kinase (TK)
promoter-driven gene for resistance to neomycin (TK-neor)
isolated from plasmid pTwu.G1 (33) was inserted at the ClaI site in plasmid pXS-37 to generate the plasmid pXS-38. Similarly, the
TK-neor fragment was inserted at the ClaI site
in plasmid pXS-18, lacking the AAV D sequences described previously
(59), to generate the plasmid pXS-39. Plasmid pXS-40 was
generated by inserting the TK-neor fragment at the
ClaI site in plasmid pSub201.
Southern blot analysis for AAV DNA rescue and replication.
DNA-mediated transfections were carried out in triplicate by the
calcium phosphate coprecipitation method (43) with 10 µg of each plasmid per 100-mm-diameter dish of 70% confluent 293 cells.
At various times posttransfection, low-Mr DNA
samples were isolated by the procedure described by Hirt
(11), digested extensively with DpnI, and
analyzed on Southern blots by using the 32P-labeled AAV DNA
probe as previously described (33, 34). HeLa cells were
transfected by using Lipofectin as recommended by the vendor
(Boehringer Mannheim Biochemicals, Indianapolis, Ind.).
Northern blot analysis for AAV gene expression.
Cells were
either mock transfected or transfected in triplicate with equivalent
amounts of various recombinant AAV plasmids by using Lipofectin as
described above. Forty-eight hours posttransfection, total cellular RNA
was isolated from two-thirds of the cells and analyzed on Northern
blots, using two 32P-labeled DNA probes, one specific for
the AAV and one specific for the glyceraldehyde phosphate dehydrogenase
(GAPDH) cDNA sequence. The remainder one-third of the cells were used
to isolate low-Mr DNA for analyses of plasmid
uptake on quantitative DNA slot blots by using the
32P-labeled AAV DNA probe as previously described
(22).
Encapsidation and biological activity of AAV progeny
virions.
Equivalent amounts of plasmids pXS-70A and
pSub201 were transfected in 293 cells as previously
described (59-62). Approximately 72 h
posttransfection, cells were harvested and progeny virions were
purified by one round of CsCl equilibrium density gradient followed by
exhaustive digestion with DNase I as previously described (21). These viral stocks were used in secondary infections
of Ad2-infected HeLa cells, and low-Mr DNA
samples isolated at various times postinfection were analyzed on
Southern blots using 32P-labeled AAV probe as previously
described (33, 34).
Stable transduction assays.
Equivalent numbers of HeLa, KB,
and 293 cells were transfected in triplicate with 10 µg each of the
recombinant plasmids pXS-38, pXS-39, and pXS-40, separately.
Forty-eight hours posttransfection, G418 was added at a final active
concentration of 400 µg/ml, and G418-resistant colonies were
enumerated 14 days later as previously described (33, 41).
 |
RESULTS |
AAV DNA sequences undergo rescue from recombinant plasmids followed
by autonomous replication in human 293 but not in HeLa cells.
Previous studies have shown that the RBS in the p5 promoter is involved
in the repression of expression of Rep78 and Rep68 proteins in the
absence of the helper virus and that the YBS is also involved in the
regulation of Rep protein expression (6, 24, 27). Further
analyses revealed that mutations in the RBS provide partial relief from
down-regulation by Rep68, and mutations in the YBS reduced the p5 mRNA
levels in 293 cells (24, 37). Since these studies were
confined to analyses of gene expression in the absence of AAV DNA
replication in experiments involving plasmid transfections, we examined
the effects of these mutations on viral DNA replication in the context
of the AAV genome. We created a number of mutations in the RBS and the
YBS within the p5 promoter of the wt AAV genome, which are
schematically depicted in Fig. 1.
Briefly, plasmid pSub201 contains the wt AAV genome (45). Plasmids pXS-70A and pXS-70B contain mutations in the RBS and the YBS, respectively, in the viral p5 promoter. In plasmid pXS-70C, both RBS and YBS have been mutated; in plasmid pXS-48B, both
sites have been deleted. Equivalent amounts of these plasmids were
transfected separately into 293 cells in the absence of adenovirus, and
low-Mr DNA samples were isolated at various
times posttransfection, digested extensively with DpnI, and
analyzed on Southern blots by using the 32P-labeled AAV DNA
probe. These results are shown in Fig. 2.
The roughly equivalent hybridization intensities of DpnI
fragments generated from each plasmid, observed even at much shorter
autoradiographic exposures, indicate that the amounts of the input
plasmids were approximately the same. It is interesting that a
low-level rescue and replication of the AAV genome from plasmid
pSub201 occurred in 293 cells, as evidenced by
time-dependent accumulation of DpnI-resistant AAV monomeric
and dimeric replicative DNA intermediates. The efficiency of rescue
and/or replication of the AAV genome in 293 cells transfected with
plasmid pXS-70A containing a mutation in the RBS was significantly increased. These replicative DNA intermediates disappeared when the
low-Mr DNA samples were digested extensively
with DpnI, which digests input plasmid DNA but not DNA
replicated in human cells, and DpnII, which digests DNA
replicated in human cells (data not shown). These results indicate that
AAV DNA containing a mutation in the RBS can undergo rescue from the
recombinant plasmid pXS-70A followed by a full round of autonomous
replication in 293 cells in the absence of adenovirus, albeit at
several orders of magnitude less than that observed from the plasmid
pSub201 in the presence of adenovirus. The efficiency of
rescue and replication of the AAV genome from plasmids pXS-70C and
pXS-48B, containing a mutation and a deletion in the RBS and the YBS,
respectively, was higher than that from plasmid pSub201 but
less than that from plasmid pXS-70A. Little rescue and/or replication
of the AAV genome occurred from the plasmid pXS-70B, which contained a
mutation in the YBS. Interestingly, however, when these studies were
carried out with HeLa cells under identical conditions, the AAV genome
failed to undergo rescue and replication, even from the plasmid pXS-70A (data not shown, but see later). Abundant rescue and/or replication of
the AAV genome from each of the plasmids occurred in the presence of
adenovirus in 293 (Fig. 3) as well as
HeLa (data not shown) cells. These results demonstrate that the RBS
mediates repression of replication and that the YBS promotes AAV DNA
replication in the absence of adenovirus in 293 cells.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 1.
Schematic structure of the AAV genome containing various
mutations and/or deletions in the RBS and the YBS in the viral p5
promoter. Mutations and deletions are denoted by the prefixes "m"
and "d." Asterisks indicate the deleted nucleotides. The AAV p5
promoter is represented by the closed circle, and the RNA start site is
indicated by the arrow. The hairpin (HP) and the D sequences that
constitute the viral ITRs are represented by open and closed
rectangles, respectively. Each of the recombinant plasmids was
constructed as described in Materials and Methods.
|
|

View larger version (92K):
[in this window]
[in a new window]
|
FIG. 2.
Southern blot analyses of rescue and replication of AAV
genomes containing various mutations and/or deletions in the RBS and
YBS in 293 cells in the absence of adenovirus. Ten micrograms of each
indicated plasmid DNA was transfected separately in approximately 70%
confluent 293 cells in a 10-cm-diameter dish, and
low-Mr DNA isolated at 24 h (lanes 1, 4, 7, 10, and 13), 48 h (lanes 2, 5, 8, 11, and 14), and 72 h
(lanes 3, 6, 9, 12, and 15) posttransfection was digested with
DpnI and analyzed on Southern blots, using an AAV-specific
DNA probe. Autoradiography was performed at 70°C for 16 h. m
and d denote the monomeric and dimeric replicative forms of the AAV
genome.
|
|

View larger version (98K):
[in this window]
[in a new window]
|
FIG. 3.
Southern blot analyses of rescue and replication of AAV
genomes containing various mutations and/or deletions in the RBS and
YBS in adenovirus-infected 293 cells. Ten micrograms of each indicated
plasmid DNA was transfected separately in approximately 70% confluent
293 cells, and low-Mr DNA isolated at 24 h
(lanes 1, 4, 7, 10, and 13), 48 h (lanes 2, 5, 8, 11, and 14), and
72 h (lanes 3, 6, 9, 12, and 15) posttransfection was digested
with DpnI and analyzed on Southern blots, using an
AAV-specific DNA probe as described in the legend to Fig. 2.
Autoradiography was performed at room temperature for 15 min. m and d
denote the monomeric and replicative forms of the AAV genome.
|
|
Autonomous replication of the AAV genomes correlates with
expression of the rep genes.
It was next of interest
to investigate whether mutations in the RBS and the YBS also had an
effect on rep gene expression. Each of the recombinant AAV
plasmids was transfected in triplicate into 293 cells in the absence of
adenovirus. Forty-eight hours posttransfection, total RNA and
low-Mr DNA were isolated and analyzed on
Northern and quantitative DNA slot blots, respectively, using the
32P-labeled AAV DNA as a probe. Such blots from two
separate experiments are shown in Fig. 4
and 5. Approximately equivalent
hybridization intensities of RNA samples with the GAPDH probe (Fig. 4)
and that of low-Mr DNA with the AAV probe (Fig.
5) indicate that RNA loads and transfection efficiency of each of the
recombinant plasmids were roughly the same. A number of conclusions can
be drawn from these data. First, the presence of the RBS represses the
expression of rep genes, especially the p5 transcripts. For
example, in cells transfected with plasmids pXS-70A, pXS-70C, or
pXS-48B, in each of which there are mutations or deletions in the RBS,
the level of p5 transcripts, and specifically the ratio of p5
transcripts to p19 or p40 transcripts, is significantly increased.
Interestingly, mutations in the YBS repress the levels of p5
transcripts. Second, the effects of the RBS and the YBS on p5
transcripts appear to be independent since the level of p5 transcript
is highest in cells transfected with plasmid pXS-70A, the lowest with
plasmid pXS-70B, and intermediate with plasmid pXS-70C. Thus, in the
absence of adenovirus, the RBS-mediated repression of the p5 promoter and the YBS-mediated stimulation of the p5 promoter appear to be
independent. Third, the extent of AAV DNA replication correlates with
the levels of p5 transcripts. For example, when the p5 transcripts are
high, the level of AAV DNA replication is also high (pXS-70A, pXS-70C,
and pXS-48B; compare Fig. 2 and 4). Fourth, the RBS and the YBS appear
to selectively affect the levels of p5 transcripts. For example,
mutations in the RBS and the YBS result in a significant increase in
the ratio of p5 transcripts to p19 and p40 transcripts. Expression of
the p5 transcripts also affects the levels of p19 and p40 transcripts
because when the level of p5 transcripts is high, the levels of p19 and
p40 transcripts are also high. When these experiments were carried out
in the presence of adenovirus, the efficiency of transcription from
each of the three AAV promoters was increased significantly, requiring
autoradiographic exposure of Northern blots only for approximately
1 h, but there was an abundant increase in the ratio of p40
transcripts to p19 or p5 transcripts (data not shown), an observation
consistent with a recently published report (25). However,
the levels of p5 transcripts in adenovirus-infected 293 cells were not
significantly different following transfection with plasmid pXS-70A or
pXS-70C but less than that with plasmid pXS-70B or pSub201
(data not shown). Thus, the RBS is required for activation of AAV
transcription by adenovirus but does not have an effect on viral DNA
replication in the presence of adenovirus.

View larger version (89K):
[in this window]
[in a new window]
|
FIG. 4.
Northern blot analyses of expression of AAV genes
containing various mutations and/or deletions in the RBS and YBS in 293 cells. Total cellular RNA was isolated from mock-transfected cells or
cells transfected with 10 µg of each indicated plasmid DNA in two
separate experiments, and 20 µg RNA from each transfectant was
analyzed on Northern blots, using an AAV-specific DNA probe. The three
viral transcripts initiating from p5, p19, and p40 promoters are
indicated. The same blots were stripped of the AAV probe and
rehybridized with the GAPDH gene probe to ascertain the equivalence of
RNA loads and transfer. Autoradiography was performed at 70°C for
72 h.
|
|

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 5.
DNA slot blot analyses of efficiency of plasmid
transfection in 293 cells. Twofold serial dilutions of 2 µg each
low-Mr DNA isolated from mock-transfected cells
or cells transfected with 10 µg of each indicated plasmid DNA from
the same two separate experiments described in the legend to Fig. 4
were analyzed on quantitative DNA slot blots, using an AAV-specific DNA
probe as described in Materials and Methods. Autoradiography was
performed at 70°C for 2 h.
|
|
Adenovirus E1A gene products are insufficient to mediate rescue and
replication of the AAV genome in HeLa cells.
As indicated above,
rescue and autonomous replication of the AAV genome from none of the
transfected recombinant plasmids could not be detected in HeLa
cells even when high-efficiency transfection protocols were used. Since
293 cells constitutively express the adenovirus early-region E1
gene products that are known to transactivate the YBS (6,
51), it was reasonable to assume that adenovirus E1A and/or E1B
gene products were responsible for the rescue and autonomous
replication of the AAV genome in 293 cells in the absence of
adenovirus. This possibility was experimentally tested when each of the
recombinant AAV plasmids was transfected into HeLa cells either in the
absence or in the presence of an expression plasmid containing the
adenovirus E1A gene. The results of these experiments are depicted in
Fig. 6. It is evident that the adenovirus
E1A gene products alone could not support rescue and replication of the
AAV genome in HeLa cells in the absence of adenovirus. Although it
remains possible that the adenovirus E1B gene products are required for
AAV DNA replication, this was not pursued further in view of the fact
that even in 293 cells, an additional factor(s), other than the
adenovirus E1A and E1B gene products, is required for autonomous
replication of AAV DNA since rescue and/or replication also occurred
from plasmids pXS-70C and pXS-48B (Fig. 2), which contain a mutation or
a deletion in the YBS.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 6.
Southern blot analyses of rescue and replication of AAV
genomes containing various mutations and/or deletions in the RBS and
YBS in HeLa cells in the absence or presence of the adenovirus E1A gene
products. Ten micrograms of each indicated plasmid DNA was transfected
separately in HeLa cells, either in the absence ( pAd2-E1A) or in the
presence (+pAd2-E1A) of an adenovirus E1A expression plasmid.
Low-Mr DNA isolated at 72 h
posttransfection was digested with DpnI and analyzed as
described in the legend to Fig. 2.
|
|
Rescue and autonomous replication of the AAV genome lead to
generation of biologically active progeny virions.
Since complete
AAV DNA replication and gene expression occurred in 293 cells, it was
next of interest to examine whether progeny AAV particles could also be
assembled in the absence of adenovirus. Plasmids pXS-70A and
pSub201 were transfected separately into 293 cells in the
absence of adenovirus as described in Materials and Methods.
Seventy-two hours posttransfection, cells were harvested and subjected
to three rounds of freezing and thawing to release virus particles,
which were purified on CsCl equilibrium density gradients followed by
exhaustive digestion with DNase I as described in Materials and
Methods. These stocks were used to infect HeLa cells in the presence of
adenovirus. Low-Mr DNA samples isolated at
various times postinfection were analyzed on Southern blots, using AAV
DNA as a probe. These results are shown in Fig.
7. Time-dependent accumulation of the
characteristic monomeric and dimeric replicative AAV DNA intermediates
could be readily detected, indicating that biologically active progeny
virions were indeed assembled following transfection of plasmids
pXS-70A and pSub201 in 293 cells in the absence of
adenovirus. These data, although not quantitative, provide further
evidence that a productive life cycle of AAV can be accomplished in 293 cells in the absence of a helper virus (42, 65).

View larger version (65K):
[in this window]
[in a new window]
|
FIG. 7.
Southern blot analyses of replication of the AAV genome
in secondary infections following autonomous rescue, replication, and
encapsidation in 293 cells. Ten-micrograms of each of plasmids pXS-70A
and pSub201 DNA was transfected separately in 293 cells, and
progeny virions were purified on CsCl equilibrium density gradients as
described in Materials and Methods. The viral stocks were used to
infect HeLa cells in the presence of adenovirus.
Low-Mr DNA isolated at 24 h (lanes 1 and
4), 48 h (lanes 2 and 5), and 72 h (lanes 3 and 6)
postinfection was analyzed on Southern blots, using an AAV-specific DNA
probe. The monomeric (m) and dimeric (d) replicative forms and the
single strands of the AAV genome (ss) are indicated. Autoradiography
was performed at 70°C for 2 h.
|
|
Autonomous replication of AAV affects stable transduction of
recombinant plasmids in 293 cells.
We next wished to determine the
consequences of rescue and autonomous replication of the AAV genome
from recombinant plasmids containing a selectable marker gene on stable
transduction. The three recombinant plasmids pXS-38, pXS-39, and
pXS-40, shown schematically in Fig. 8,
were constructed as described in Materials and Methods. Plasmid pXS-40
contains the intact wt AAV genome. Plasmid pXS-39 contains an AAV
genome from which the D sequences have been deleted, and plasmid pXS-38
contains an AAV genome in which the D sequences have been replaced by
the adenovirus ITRs. Each of the plasmids also contains the herpesvirus
(TK-neor) gene in the vector backbone. The efficiency of
rescue and replication of the AAV genome from these plasmids in
adenovirus-infected cells varies greatly, ranging from very high
(pXS-40) to low (pXS-39) due to D-sequence deletions
(59-61). Little or no rescue and replication of the AAV
genome occur from plasmid pXS-38 (data not shown). These plasmids were
transfected into HeLa, KB, and 293 cells separately under identical
conditions, and G418-resistant colonies were enumerated as described in
Materials and Methods. These results are shown in Table
1. It is evident that the total numbers
of G418-resistant colonies obtained with all three plasmids in HeLa or
KB cells were not significantly different for the given cell types,
although the transduction efficiency in HeLa cells was approximately
threefold higher than that in KB cells. In 293 cells, however, the
numbers of G418-resistant colonies obtained with these plasmids varied significantly. We interpret these results as follows. Since no rescue
and replication of the AAV genome from any of the plasmids occur in
HeLa or KB cells (data not shown), the plasmid integrity is maintained,
leading to stable integration. Plasmid pXS-38, from which the AAV
genome does not undergo rescue and replication in 293 cells, is highly
efficient in yielding G418-resistant colonies. With plasmid pXS-39,
from which a low-level rescue and replication of the AAV genome occur
in 293 cells, there is approximately fourfold reduction in the number
of G418-resistant colonies, and with plasmid pXS-40, from which the AAV
genome undergoes efficient rescue and replication, the numbers of
G418-resistant colonies are further reduced approximately fivefold.
These data are consistent with the conclusion that rescue and
autonomous replication of the AAV genome from recombinant plasmids in
293 cells compromise the structural integrity of the transfected
plasmid, leading to reduction in functional DNA molecules capable of
stable integration into the host chromosome (33).

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 8.
Schematic structures of recombinant AAV plasmids
containing the neor selectable marker gene and deletion or
substitution in the D sequence in the viral ITRs. The hairpin (HP) and
D sequences are denoted by the open and closed boxes, respectively. The
adenovirus ITRs are denoted by boxes with vertical lines, and the
neor gene is represented by cross-hatched boxes. Each of
the recombinant plasmids was constructed as described in Materials and
Methods.
|
|
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Effects of rescue and autonomous replication of the AAV
genome from recombinant plasmids on stable transfection in HeLa, KB,
and 293 cellsa
|
|
 |
DISCUSSION |
More than a decade ago, Yakobson et al. (65) first
documented that AAV is capable of undergoing a completely productive replication in the absence of a helper virus, albeit inefficiently, in
certain cell types treated with various genotoxic stress. Since expression from the viral p5 promoter and the interaction of AAV Rep
proteins with the viral regulatory elements play a crucial role in a
productive infection by AAV, Kyöstiö et al. (24) and Ni et al. (35) investigated these steps in the virus
life cycle, but those studies were carried out in the absence of AAV DNA replication. We undertook the present study to delineate the role
of AAV Rep proteins and their interaction with the regulatory elements
in the p5 promoter in the context of a complete wt viral genome.
Consistent with previous studies, our data indicate that mutations in
the RBS relieve Rep protein-mediated suppression of expression of the
viral p5 transcripts and that mutations in the YBS augment Rep
protein-mediated suppression of expression from the p5 promoter
(24, 37).
More interestingly, our data document that AAV is capable of autonomous
replication, even in the absence of any genotoxic stress, but only in
293 cells. Autonomous replication of AAV in 293 cells was not detected
during infection studies when a multiplicity of infection of 20 (approximately 2,000 viral genomes/cell) was used (65). We
suspect that we detected a low-level replication of AAV in the absence
of adenovirus because substantially larger numbers (>500,000 viral
genomes/cell) were delivered in 293 cells during plasmid-mediated
transfections (39, 40). Abundant expression of viral
transcripts occurs from transfected recombinant plasmids, even in the
absence of adenovirus, which does not lead to efficient replication of
viral genomes (25), suggesting suboptimal transport to the
cytoplasm and/or inefficient translation of these transcripts. In the
presence of adenovirus, on the other hand, these processes are carried
out more efficiently (46). The fact that the adenovirus early gene products alone did not support rescue and replication of the
AAV genome in HeLa cells in the absence of adenovirus suggests that
additional factors other than the adenovirus E1A gene products are
required for the autonomous replication of AAV DNA. The observation that even in 293 cells no rescue and/or replication occurred from a
recombinant plasmids that contained a mutation or a deletion in the YBS
indicates that factors other than E1A and E1B are required for
autonomous replication.
The regulation of expression from the AAV promoters in general, and
that from the p5 promoter in particular, is complex (24, 25, 37,
38). The roles of two control elements in the p5 promoter, the
RBS and the YBS, have been studied in some detail (24, 37).
Although the RBS, which is localized between the p5 TATA box and the
transcription start site (Fig. 1), appears to be crucial in effectively
repressing expression from the p5 promoter during a natural infection
by AAV, detectable levels of transcripts from each of the AAV promoters
could be obtained in 293 cells following plasmid transfections, an
observation consistent with previously published reports (23,
25). Although the latter means might not represent a
physiologically natural situation, it provides some explanation for why
AAV is unable to undergo autonomous replication: presumably because a
threshold concentration of the viral Rep proteins fails to accumulate.
This contention is borne out by the fact that there was a strong
correlation between the levels of the p5 transcripts and the ability of
AAV to replicate autonomously in 293 cells (Fig. 2 and 4). With
reference to the YBS, we focused our studies only on the site which is
localized downstream from the p5 TATA box and the RBS because a second
YBS, which is present upstream of the p5 TATA box, binds to YY1 and mediates repression of expression from the p5 promoter in the absence
of adenovirus, and the adenovirus E1A-YY1 complex formation relieves
this repression (6, 50, 51).
In sum, our studies document that the Rep protein interaction with the
RBS plays a dominant role in down-regulating viral gene expression from
the p5 promoter, and perturbation in this interaction is sufficient to
confer autonomous replication competence to AAV in 293 cells. Since
autonomous replication of the AAV genome does not occur in HeLa cells,
even in the presence of adenovirus early gene products, these studies
also suggest that additional, hitherto unknown viral and/or cellular
factors are required for a productive infection by AAV.
 |
ACKNOWLEDGMENTS |
We thank Richard J. Samulski for providing plasmid
pSub201.
This research was supported in part by the Public Health Service grants
(HL-48342, HL-53586, HL-58881, and DK-49218, Centers of Excellence in
Molecular Hematology) from the National Institutes of Health and by a
grant from the Phi Beta Psi sorority. A.S. was supported by an
Established Investigator Award from the American Heart Association.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Microbiology and Immunology, 635 Barnhill Dr., Medical Science
Building, Room 231-B, Indiana University School of Medicine,
Indianapolis, IN 46202-5120. Phone: (317) 274-2194. Fax: (317)
274-4090. E-mail: asrivast{at}iupui.edu.
 |
REFERENCES |
| 1.
|
Ashktorab, H., and A. Srivastava.
1989.
Identification of nuclear proteins that specifically interact with adeno-associated virus type 2 inverted terminal repeat hairpin DNA.
J. Virol.
63:3034-3039[Abstract/Free Full Text].
|
| 2.
|
Berns, K. I.
1990.
Parvovirus replication.
Microbiol. Rev.
54:316-329[Abstract/Free Full Text].
|
| 3.
|
Berns, K. I., and R. A. Bohenzky.
1987.
Adeno-associated viruses: an update.
Adv. Virus Res.
32:243-306[Medline].
|
| 4.
|
Berns, K. I.,
R. M. Kotin, and M. A. Labow.
1988.
Regulation of adeno-associated virus DNA replication.
Biochim. Biophys. Acta
95:425-429.
|
| 5.
|
Buller, R. M.,
J. E. Janik,
E. D. Sebring, and J. A. Rose.
1981.
Herpes simplex virus types 1 and 2 completely help adeno-associated virus replication.
J. Virol.
40:241-247[Abstract/Free Full Text].
|
| 6.
|
Chang, L.-S.,
Y. Shi, and T. Shenk.
1989.
Adeno-associated virus p5 promoter contains an adenovirus E1A-inducible element and a binding site for the major late transcription factor.
J. Virol.
63:3479-3488[Abstract/Free Full Text].
|
| 7.
|
Cheung, A. K. M.,
M. D. Hoggan,
W. W. Hauswirth, and K. I. Berns.
1980.
Integration of the adeno-associated virus genome into cellular DNA in latently infected human Detroit 6 cells.
J. Virol.
33:739-748[Abstract/Free Full Text].
|
| 8.
|
Giraud, C.,
E. Winocour, and K. I. Berns.
1995.
Recombinant junctions formed by site-specific integration of adeno-associated virus into an episome.
J. Virol.
69:6917-6924[Abstract].
|
| 9.
|
Hauswirth, W. W., and K. I. Berns.
1977.
Origin and termination of adeno-associated virus DNA replication.
Virology
78:488-499[Medline].
|
| 10.
|
Hermonat, P. L.,
M. A. Labow,
R. Wright,
K. I. Berns, and N. Muzyczka.
1984.
Genetics of adeno-associated virus: isolation and preliminary characterization of adeno-associated virus type 2 mutants.
J. Virol.
51:329-339[Abstract/Free Full Text].
|
| 11.
|
Hirt, B.
1967.
Selective extraction of polyoma DNA from infected mouse cell cultures.
J. Mol. Biol.
26:365-367[Medline].
|
| 12.
|
Hong, G.,
P. Ward, and K. I. Berns.
1992.
In vitro replication of adeno-associated virus DNA.
Proc. Natl. Acad. Sci. USA
89:4673-4677[Abstract/Free Full Text].
|
| 13.
|
Hong, G.,
P. Ward, and K. I. Berns.
1994.
Intermediates of adeno-associated virus DNA replication in vitro.
J. Virol.
68:2011-2015[Abstract/Free Full Text].
|
| 14.
|
Im, D.-S., and N. Muzyczka.
1989.
Factors that bind to adeno-associated virus terminal repeats.
J. Virol.
63:3095-3104[Abstract/Free Full Text].
|
| 15.
|
Im, D.-S., and N. Muzyczka.
1990.
The AAV origin binding protein Rep68 is an ATP-dependent site-specific endonuclease with DNA helicase activity.
Cell
61:447-457[Medline].
|
| 16.
|
Im, D.-S., and N. Muzyczka.
1992.
Partial purification of adeno-associated virus Rep78, Rep52, and Rep40 proteins and their biochemical characterization.
J. Virol.
66:1119-1128[Abstract/Free Full Text].
|
| 17.
|
Kotin, R. M., and K. I. Berns.
1989.
Organization of adeno-associated virus DNA in latently infected Detroit 6 cells.
Virology
170:460-467[Medline].
|
| 18.
|
Kotin, R. M.,
R. M. Linden, and K. I. Berns.
1992.
Characterization of a preferred site on human chromosome 19q for integration of adeno-associated virus DNA by nonhomologous recombination.
EMBO J.
11:5071-5078[Medline].
|
| 19.
|
Kotin, R. M.,
J. C. Menninger,
D. C. Ward, and K. I. Berns.
1991.
Mapping and direct visualization of a region-specific viral DNA integration site on chromosome 19q13-qter.
Genomics
10:831-834[Medline].
|
| 20.
|
Kotin, R. M.,
M. Siniscalco,
R. J. Samulski,
X. Zhu,
L. Hunter,
C. A. Laughlin,
S. McLaughlin,
N. Muzyczka,
M. Rocchi, and K. I. Berns.
1990.
Site-specific integration by adeno-associated virus.
Proc. Natl. Acad. Sci. USA
87:2211-2215[Abstract/Free Full Text].
|
| 21.
|
Kube, D. M.,
S. Ponnazhagan, and A. Srivastava.
1997.
Encapsidation of adeno-associated virus type 2 Rep proteins in wild-type and recombinant progeny virions: Rep-mediated growth inhibition of primary human cells.
J. Virol.
71:7361-7371[Abstract].
|
| 22.
|
Kube, D. M., and A. Srivastava.
1997.
Quantitative DNA slot blot analysis: inhibition of DNA binding to membranes by magnesium ions.
Nucleic Acids Res.
25:3375-3376[Abstract/Free Full Text].
|
| 23.
|
Kyöstiö, S. R. M.,
R. A. Owens,
M. D. Weitzman,
B. A. Antoni,
N. Chejanovsky, and B. J. Carter.
1994.
Analysis of the adeno-associated virus (AAV) wild-type and mutant Rep proteins for their ability to regulate negatively AAV p5 and p19 mRNA levels.
J. Virol.
68:2947-2957[Abstract/Free Full Text].
|
| 24.
|
Kyöstiö, S. R. M.,
R. S. Wonderling, and R. A. Owens.
1995.
Negative regulation of the adeno-associated virus (AAV) p5 promoter involves both the p5 rep binding site and the consensus ATP-binding motif of the AAV Rep68 protein.
J. Virol.
69:6787-6796[Abstract].
|
| 25.
|
Li, J.,
R. J. Samulski, and X. Xiao.
1997.
Role of highly regulated rep gene expression in adeno-associated virus vector production.
J. Virol.
71:5236-5243[Abstract].
|
| 26.
|
Lusby, E.,
K. H. Fife, and K. I. Berns.
1980.
Nucleotide sequence of the inverted terminal repetition in adeno-associated virus DNA.
J. Virol.
34:402-409[Abstract/Free Full Text].
|
| 27.
|
McCarty, D. M.,
D. J. Pereira,
I. Zolotukhin,
X. Zhou,
J. H. Ryan, and N. Muzyczka.
1994.
Identification of linear DNA sequences that specifically bind the adeno-associated virus Rep protein.
J. Virol.
68:4988-4997[Abstract/Free Full Text].
|
| 28.
|
McCarty, D. M.,
J. H. Ryan,
S. Zolotukhin,
X. Zhou, and N. Muzyczka.
1994.
Interaction of the adeno-associated virus Rep protein with a sequence within the palindrome of the viral terminal repeat.
J. Virol.
68:4998-5006[Abstract/Free Full Text].
|
| 29.
|
Mendelson, E.,
M. G. Smith,
I. L. Miller, and B. J. Carter.
1988.
Effect of viral rep gene on transformation of cells by adeno-associated virus vector.
Virology
166:612-615[Medline].
|
| 30.
|
Muzyczka, N.
1992.
Use of adeno-associated virus as a general transduction vector for mammalian cells.
Curr. Top. Microbiol. Immunol.
158:97-129[Medline].
|
| 31.
|
Nahreini, P., and A. Srivastava.
1989.
Rescue and replication of the adeno-associated virus 2 genome in mortal and immortal human cells.
Intervirology
30:74-85[Medline].
|
| 32.
|
Nahreini, P., and A. Srivastava.
1992.
Rescue of the adeno-associated virus 2 genome correlates with alterations in DNA-modifying enzymes in human cells.
Intervirology
33:109-115[Medline].
|
| 33.
|
Nahreini, P.,
S. H. Larsen, and A. Srivastava.
1992.
Cloning and integration of DNA fragments in human cells via the inverted terminal repeats of the adeno-associated virus 2 genome.
Gene
119:265-272[Medline].
|
| 34.
|
Nahreini, P.,
M. J. Woody,
S. Z. Zhou, and A. Srivastava.
1993.
Versatile adeno-associated virus 2-based vectors for constructing recombinant virions.
Gene
124:257-262[Medline].
|
| 35.
|
Ni, T. H.,
X. H. Zhou,
D. M. McCarty,
I. Zolotukhin, and N. Muzyczka.
1994.
In vitro replication of adeno-associated virus DNA.
J. Virol.
68:1128-1138[Abstract/Free Full Text].
|
| 36.
|
Owens, R. A., and B. J. Carter.
1992.
In vitro resolution of adeno-associated virus DNA hairpin termini by wild-type Rep protein is inhibited by a dominant-negative mutant of Rep.
J. Virol.
66:1236-1240[Abstract/Free Full Text].
|
| 37.
|
Pereira, D. J.,
D. M. McCarty, and N. Muzyczka.
1997.
The adeno-associated virus (AAV) Rep protein acts as both a repressor and an activator to regulate AAV transcription during a productive infection.
J. Virol.
71:1079-1088[Abstract].
|
| 38.
|
Pereira, D. J., and N. Muzyczka.
1997.
The cellular transcription factor SP1 and an unknown cellular protein are required to mediate Rep protein activation of the adeno-associated virus p19 promoter.
J. Virol.
71:1747-1756[Abstract].
|
| 39.
|
Ponnazhagan, S.,
X.-S. Wang,
M. J. Woody,
F. Luo,
L. Y. Kang,
M. L. Nallari,
N. C. Munshi,
S. Z. Zhou, and A. Srivastava.
1996.
Differential expression from p6 promoter of parvovirus B19 in human cells following plasmid transfection and recombinant adeno-associated virus 2 (AAV) infection: human megakaryocytic leukaemia cells are non-permissive for AAV infection.
J. Gen. Virol.
77:1111-1122[Abstract/Free Full Text].
|
| 40.
|
Ponnazhagan, S.,
M. J. Woody,
X.-S. Wang,
S. Z. Zhou, and A. Srivastava.
1995.
Transcriptional transactivation of parvovirus B19 promoters in nonpermissive human cells by adenovirus type 2.
J. Virol.
69:8096-8101[Abstract].
|
| 41.
|
Qing, K. Y.,
B. Khuntirat,
C. Mah,
D. M. Kube,
X.-S. Wang,
S. Ponnazhagan,
S. Z. Zhou,
V. J. Dwarki,
M. C. Yoder, and A. Srivastava.
1998.
Adeno-associated virus type 2-mediated gene transfer: correlation of tyrosine phosphorylation of the cellular single-stranded D sequence-binding protein with transgene expression in human cells in vitro and murine tissues in vivo.
J. Virol.
72:1593-1599[Abstract/Free Full Text].
|
| 42.
|
Qing, K. Y.,
X.-S. Wang,
D. M. Kube,
S. Ponnazhagan,
A. Bajpai, and A. Srivastava.
1997.
Role of tyrosine phosphorylation of a cellular protein in adeno-associated virus 2-mediated transgene expression.
Proc. Natl. Acad. Sci. USA
94:10879-10884[Abstract/Free Full Text].
|
| 43.
|
Sambrook, J.,
E. F. Fritsch, and T. Maniatis.
1989.
In
Molecular cloning: a laboratory manual, p. 1.53-1.110.
Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
|
| 44.
|
Samulski, R. J.,
K. I. Berns,
M. Tan, and N. Muzyczka.
1982.
Cloning of adeno-associated virus into pBR322: rescue of intact virus from the recombinant plasmid in human cells.
Proc. Natl. Acad. Sci. USA
79:2077-2081[Abstract/Free Full Text].
|
| 45.
|
Samulski, R. J.,
L.-S. Chang, and T. Shenk.
1987.
A recombinant plasmid from which an infectious adeno-associated virus genome can be excised in vitro and its use to study viral replication.
J. Virol.
61:3096-3101[Abstract/Free Full Text].
|
| 46.
|
Samulski, R. J., and T. Shenk.
1988.
Adenovirus E1B 55-Mr polypeptide facilitates timely cytoplasmic accumulation of adeno-associated virus mRNAs.
J. Virol.
62:206-210[Abstract/Free Full Text].
|
| 47.
|
Samulski, R. J.,
A. Srivastava,
K. I. Berns, and N. Muzyczka.
1983.
Rescue of adeno-associated virus from recombinant plasmids: gene correction within the terminal repeats of AAV.
Cell
33:135-143[Medline].
|
| 48.
|
Samulski, R. J.,
X. Zhu,
X. Xiao,
J. Brook,
D. E. Houseman,
N. Epstein, and L. A. Hunter.
1991.
Targeted integration of adeno-associated virus (AAV) into human chromosome 19.
EMBO J.
10:3941-3950[Medline].
|
| 49.
|
Senapathy, P.,
J.-D. Tratschin, and B. J. Carter.
1984.
Replication of adeno-associated virus DNA: complementation of naturally occurring rep mutants by a wild-type genome or an ori mutant and correction of terminal palindrome deletions.
J. Mol. Biol.
179:1-20[Medline].
|
| 50.
|
Seto, Y.,
Y. Shi, and T. Shenk.
1991.
YY1 is an initiator sequence-binding protein that directs and activates transcription in vitro.
Nature
354:241-245[Medline].
|
| 51.
|
Shi, Y.,
E. Seto,
L.-S. Chang, and T. Shenk.
1991.
Transcriptional repression by YY1, a human GL1-Krüppel-related protein, and relief of repression by adenovirus E1A protein.
Cell
67:377-388[Medline].
|
| 52.
|
Snyder, R. O.,
D.-S. Im,
T.-H. Ni,
X. Xiao,
R. J. Samulski, and N. Muzyczka.
1993.
Features of the adeno-associated virus origin involved in substrate recognition by the viral Rep protein.
J. Virol.
67:6096-6104[Abstract/Free Full Text].
|
| 53.
|
Snyder, R. O.,
R. J. Samulski, and N. Muzyczka.
1990.
In vitro resolution of covalently joined AAV chromosome ends.
Cell
60:105-113[Medline].
|
| 54.
|
Srivastava, A.
1987.
Replication of the adeno-associated virus DNA termini in vitro.
Intervirology
27:138-147[Medline].
|
| 55.
|
Srivastava, A.,
E. W. Lusby, and K. I. Berns.
1983.
Nucleotide sequence and organization of the adeno-associated virus 2 genome.
J. Virol.
45:555-564[Abstract/Free Full Text].
|
| 56.
|
Tratschin, J.-D.,
I. L. Miller, and B. J. Carter.
1984.
Genetic analysis of adeno-associated virus: properties of deletion mutants constructed in vitro and evidence for an adeno-associated virus replication function.
J. Virol.
51:611-619[Abstract/Free Full Text].
|
| 57.
|
Urcelay, E.,
P. Ward,
S. M. Weiner,
B. Safer, and R. M. Kotin.
1995.
Asymmetric replication in vitro from a human sequence element is dependent on adeno-associated virus Rep protein.
J. Virol.
69:2038-2046[Abstract].
|
| 58.
|
Usheva, A., and T. Shenk.
1996.
YY1 transcription initiator: protein interactions and association with a DNA site containing unpaired strands.
Proc. Natl. Acad. Sci. USA
93:13571-13576[Abstract/Free Full Text].
|
| 59.
|
Wang, X.-S.,
S. Ponnazhagan, and A. Srivastava.
1995.
Rescue and replication signals of the adeno-associated virus 2 genome.
J. Mol. Biol.
250:573-580[Medline].
|
| 60.
|
Wang, X.-S.,
S. Ponnazhagan, and A. Srivastava.
1996.
Rescue and replication of adeno-associated virus type 2 as well as vector DNA sequences from recombinant plasmids containing deletions in the viral inverted terminal repeats: selective encapsidation of viral genomes in progeny virions.
J. Virol.
70:1668-1677[Abstract].
|
| 61.
|
Wang, X.-S.,
K. Y. Qing,
S. Ponnazhagan, and A. Srivastava.
1997.
Adeno-associated virus type 2 DNA replication in vivo: mutation analyses of the D sequence in viral inverted terminal repeats.
J. Virol.
71:3077-3082[Abstract].
|
| 62.
|
Wang, X.-S., and A. Srivastava.
1997.
A novel terminal resolution-like site in the adeno-associated virus type 2 genome.
J. Virol.
71:1140-1146[Abstract].
|
| 63.
|
Ward, P., and K. I. Berns.
1991.
In vitro rescue of an integrated hybrid adeno-associated virus/simian virus 40 genome.
J. Mol. Biol.
218:791-804[Medline].
|
| 64.
|
Ward, P.,
E. Urcelay,
R. M. Kotin,
B. Safer, and K. I. Berns.
1994.
Adeno-associated virus DNA replication in vitro: activation by a maltose-binding protein/Rep68 fusion protein.
J. Virol.
68:6029-6037[Abstract/Free Full Text].
|
| 65.
|
Yakobson, B.,
T. Koch, and E. Winocour.
1987.
Replication of adeno-associated virus in synchronized cells without the addition of a helper virus.
J. Virol.
61:972-981[Abstract/Free Full Text].
|
J Virol, June 1998, p. 4811-4818, Vol. 72, No. 6
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Murphy, M., Gomos-Klein, J., Stankic, M., Falck-Pedersen, E.
(2007). Adeno-Associated Virus Type 2 p5 Promoter: a Rep-Regulated DNA Switch Element Functioning in Transcription, Replication, and Site-Specific Integration. J. Virol.
81: 3721-3730
[Abstract]
[Full Text]
-
Cathomen, T., Stracker, T. H., Gilbert, L. B., Weitzman, M. D.
(2001). A genetic screen identifies a cellular regulator of adeno-associated virus. Proc. Natl. Acad. Sci. USA
10.1073/pnas.261567198v1
[Abstract]
[Full Text]
-
Ogston, P., Raj, K., Beard, P.
(2000). Productive Replication of Adeno-Associated Virus Can Occur in Human Papillomavirus Type 16 (HPV-16) Episome-Containing Keratinocytes and Is Augmented by the HPV-16 E2 Protein. J. Virol.
74: 3494-3504
[Abstract]
[Full Text]
-
Wang, X.-S., Khuntirat, B., Qing, K., Ponnazhagan, S., Kube, D. M., Zhou, S., Dwarki, V. J., Srivastava, A.
(1998). Characterization of Wild-Type Adeno-Associated Virus Type 2-Like Particles Generated during Recombinant Viral Vector Production and Strategies for Their Elimination. J. Virol.
72: 5472-5480
[Abstract]
[Full Text]
-
Cathomen, T., Stracker, T. H., Gilbert, L. B., Weitzman, M. D.
(2001). A genetic screen identifies a cellular regulator of adeno-associated virus. Proc. Natl. Acad. Sci. USA
98: 14991-14996
[Abstract]
[Full Text]